(firstQuint)Simeprevir in Combination With Sofosbuvir in Treatment-Nave or -Experienced Adults With Chronic Genotype 4 Hepatitis C Virus Infection.

 Patients with confirmed absence of cirrhosis will receive 8 weeks of treatment with Sofosbuvir and Simeprevir.

 Patients with confirmed presence of cirrhosis will receive 12 weeks of treatment with Sofosbuvir and Simeprevir.

 All patients will followed for 24 weeks post-treatment.

 Presence or absence of cirrhosis will be evaluated by FibroScan if no historical liver biopsy or FibroScan is available.

.

 Simeprevir in Combination With Sofosbuvir in Treatment-Nave or -Experienced Adults With Chronic Genotype 4 Hepatitis C Virus Infection@highlight

This study will look at the safety and efficacy of 8 week and 12 week treatment with Sofosbuvir and Simeprevir in treatment-naive and treatment-experienced patients with chronic hepatitis C genotype 4.

